PRAGMATIC-SEMICONDUCTOR
Today, Pragmatic Semiconductor was honoured to welcome HRH The Princess Royal to officially open the UK’s first 300mm semiconductor wafer fabrication line (fab) at Pragmatic Park in Durham. The advanced manufacturing facility produces chips based on Pragmatic’s innovative and unique flexible integrated circuit technology. HRH The Princess Royal was hosted by David Moore, CEO, Pragmatic Semiconductor, with a tour of the clean room and facilities, followed by an unveiling of a site plaque to mark the occasion. Attendees included key customers, ecosystem partners, investors and government officials.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240327583783/en/
The UK’s first 300mm semiconductor fabrication line at Pragmatic Park, Durham, UK (Photo: Business Wire)
Pragmatic’s FlexICs are low-cost, more sustainable alternatives to silicon chips, ultra-thin, with a flexible form factor they enable connect, sense and compute capabilities, fuelling the Internet of Things (IoT) across multiple sectors including consumer, industrial, healthcare and beyond. The company’s mission is to provide item level intelligence to trillions of smart objects over the next decade across a wide range of applications with significant opportunities in smart packaging of fast-moving consumer goods that will significantly improve levels of reuse and recycling, transforming waste management, and enabling a circular economy. Other use cases include wearables, sensors and flexible controllers.
Pragmatic Park has capacity to host up to nine fabrication lines, each capable of producing billions of chips per year. Pragmatic’s pioneering sustainable approach extends to its manufacturing, using fewer process steps and a more concentrated footprint, than standard silicon fabs. The company’s innovative, optimised manufacturing process supports extremely rapid production cycles of less than 48 hours, at very low cost. The manufacturing process also uses significantly less energy and less water than typical silicon manufacturing, and fewer harmful gases. Pragmatic’s modular ‘Fab-in-a-Box’ approach, supports co-location of end-to-end FlexIC manufacturing at customers sites, rationalising extended supply chains and providing additional levels of security and resilience. The manufacturing facility enables the company to meet the growing demand for its unique technology from customers worldwide. Over the next five years Pragmatic anticipates creating over 500 highly skilled jobs in the North-East of England and Cambridge.
Dave Moore, CEO, Pragmatic Semiconductor said: "Today’s official opening marks a key milestone in Pragmatic’s growth trajectory and for the UK on the global semiconductor stage. I am incredibly proud of what the team has achieved and the ambition of our mission to enable item level intelligence in over a trillion sustainable, smart items over the next decade. Such intelligence at scale has the power to accelerate the digital transformation across industries. Sustainability is at the very core of our technology and extends to how FlexICs enable our customers to further drive innovations and pathways through their products and services towards global net zero goals.”
Francisco Melo, President Solutions Group, Avery Dennison said: “The key to any effective collaboration is a shared mindset. Pragmatic’s innovative approach is reflective of our own, as is its commitment to helping solve business challenges. The opening of an advanced manufacturing chip facility is fantastic news for all technology innovators. Congratulations to Pragmatic on such an important and impressive achievement. I look forward to our clients harnessing the potential of Pragmatic's flexible integrated circuits as part of our evolving inlay portfolio."
Simon Little, Banking & Investments Director, UKIB and Pragmatic Board member said: “The Bank invested in Pragmatic to support low carbon domestic manufacturing of semiconductors in the UK. The official opening of Pragmatic Park in Durham marks a pivotal next step in its journey, and we look forward to seeing the long-term impact of our investment, as Pragmatic scales up its operation and creates highly skilled jobs here in the North-East.”
Niranjan Sirdeshpande, Global Head of M&G’s Catalyst strategy and Pragmatic Board member said: “The UK has a very supportive ecosystem for providing early-stage funding, but it becomes challenging for businesses looking for later stage capital. By providing growth equity to enterprising tech disruptors such as Pragmatic, M&G’s £5 billion Catalyst strategy can help them to scale, provide expertise and partner with them all the way to success. Put to work in this way, patient capital can support economic growth and capture value for peoples' pensions and savings as we transition to a more sustainable economy. We are proud to support Pragmatic’s work in Durham with tech advancement in this critical part of the UK's national infrastructure.”
About Pragmatic Semiconductor
Pragmatic is revolutionising semiconductor fabrication with ultra-low-cost, flexible integrated circuit (FlexIC) technology that makes it quick and easy to embed intelligence almost anywhere.
With rapid cycle times that substantially accelerate time to market, its foundry provides high-volume fabrication at a fraction of the cost of silicon, with a significantly lower environmental impact.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240327583783/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press release
Agreement Marks Significant Step Towards Increasing Italy’s Contribution to advancing Lunar Exploration ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
Perma-Pipe International Holdings, Inc. Announces Third Quarter Financial Results23.12.2024 18:43:00 CET | Press release
The Company generated net sales of $41.6 million for the quarter and $113.4 million year-to-dateIncome before income taxes of $5.1 million for the quarter and $13.2 million year-to-dateBacklog of $114.2 million at October 31, 2024, compared to $68.5 million at January 31, 2024 Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) announced today financial results for the second quarter and fiscal year-to-date period ended October 31, 2024. "Net sales for the third quarter were $41.6 million, a decrease of $4.1 million, as compared to the same quarter last year. Net income attributable to common stock of $2.5 million was an increase of $0.5 million, or 29%, compared to $1.9 million in the third quarter of 2023. For the nine months ended October 31, 2024, net sales of $113.4 million represent an increase of 3% compared to the nine months ended October 31, 2023. The net income attributable to common stock of $7.2 million was an increase of $5.4 million, or 294%, compared to net income at
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom